Dennis Miller

Dennis Miller currently serves as the SVP, Product Development Leader at Just - Evotec Biologics since February 2023. As President of CPTXBio LLC since October 2011, Dennis has been providing expert consulting in clinical pharmacology, toxicology, and pharmacokinetics, particularly concerning biologics-based therapeutics. Previously, Dennis held significant roles at Blaze Bioscience, leading the development of tozuleristide through to Phase 1 clinical trials, and at ZymoGenetics Inc, managing research and preclinical development while participating in executive strategy. Earlier experience includes a directorial role at Seattle Genetics overseeing clinical pharmacology and toxicology, as well as an associate directorship at Amgen. Educational qualifications include a Ph.D. in biochemistry from the University of Utah, along with degrees from Utah State University, Michigan State University, and the University of Rochester.